Editorial: Digital therapeutics: using software to treat, manage, and prevent disease.
| Autor: | Smayda KE; MedRhythms, Portland, ME, United States., Campellone T; Woebot Labs Inc., San Francisco, CA, United States., Taylor SR; MedRhythms, Portland, ME, United States., Harris B; MedRhythms, Portland, ME, United States., Ellis TD; College of Health and Rehabilitation Sciences, Sargent College, Boston University, Boston, MA, United States., Awad LN; College of Health and Rehabilitation Sciences, Sargent College, Boston University, Boston, MA, United States. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Frontiers in digital health [Front Digit Health] 2023 Sep 25; Vol. 5, pp. 1261124. Date of Electronic Publication: 2023 Sep 25 (Print Publication: 2023). |
| DOI: | 10.3389/fdgth.2023.1261124 |
| Abstrakt: | Competing Interests: LA is a paid advisor for MedRhythms. BH is the CEO of and is employed by MedRhythms and holds stock options in the company. ST is employed by MedRhythms and holds stock options in the company. KS is employed by MedRhythms and holds stock options in the company. TC is employed by Woebot Health and holds stock options in Click Therapeutics. TE has received grant funding from MedRhythms. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|